Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Medtronic Makes Another Big Play In A-Fib, Purchases Ablation Frontiers

This article was originally published in The Gray Sheet

Executive Summary

Medtronic will add anatomically designed radiofrequency ablation catheters for treatment of atrial fibrillation to its fledgling AF Solutions division through the purchase of privately held Ablation Frontiers

You may also be interested in...



Medtronic Gears Up For FDA Panel With Mixed Results From AF Ablation Trial

Medtronic could face more questions than expected at an FDA advisory panel meeting later this month for the firm’s Phased RF Ablation System for atrial fibrillation due to mixed pivotal trial results released last week.

Medtronic Gears Up For FDA Panel With Mixed Results From AF Ablation Trial

Medtronic could face more questions than expected at an FDA advisory panel meeting later this month for the firm’s Phased RF Ablation System for atrial fibrillation due to mixed pivotal trial results released last week.

Regulatory News In Brief

Two a-fib devices go to panel

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

MT027007

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel